Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with

Hao Song1, Qi Wang, Yang Guo

  • 1MOA Key Laboratory of Animal Biotechnology of National Ministry of Agriculture, Institute of Veterinary Immunology, and Research Laboratory of Virology, Immunology & Bioinformatics, Division of Veterinary Microbiology & Virology, Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A & F University, Yangling, Xi'an City, Shaanxi Province, 712100, China.

Abstract

Insights

This study identifies specific microRNAs (miRNAs) as potential biomarkers for severe H1N1 influenza infection. These miRNAs, found in peripheral blood mononuclear cells (PBMCs), regulate key pathways and could offer new therapeutic targets for critical influenza cases.

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Influenza pandemics pose significant health and economic threats, necessitating a deeper understanding of host responses.
  • MicroRNAs (miRNAs) play a role in pathogen-host interactions, but their specific involvement in severe human influenza, particularly in critically ill patients, remains unclear.

Purpose of the Study:

  • To identify cellular miRNAs involved in the host response to influenza virus infection in critically ill patients.
  • To evaluate the diagnostic accuracy of identified miRNAs for severe H1N1 influenza.
  • To construct a miRNA-mediated host-pathogen interaction network.

Main Methods:

  • Comprehensive miRNA profiling of peripheral blood mononuclear cells (PBMCs) from critically ill H1N1 patients using miRNA microarray and qRT-PCR.
  • Receiver operator characteristic (ROC) curve analysis to assess diagnostic value.
  • Integrative network construction of miRNA-gene and protein-protein interactions using Cytoscape.

Main Results:

  • Forty-one differentially expressed miRNAs were identified; nine were validated by qRT-PCR.
  • miR-31, miR-29a, and miR-148a showed significant diagnostic potential for severe H1N1 influenza (AUCs 0.9510, 0.8951, 0.8811).
  • Network analysis revealed miRNA regulation of key pathways (MAPK, EGFR, Toll-like receptor) and identified altered expression of host genes (e.g., TP53, TGFBR1, JAK2, CASP3, IL10, MX1).

Conclusions:

  • Dysregulated miRNAs in PBMCs of H1N1 patients modulate key genes in major signaling pathways relevant to influenza infection.
  • These differentially expressed miRNAs represent potential therapeutic targets and biomarkers for severe influenza virus infection.

Related Concept Videos